IntegerBio is proud of our collaboration with The Rosalind Franklin Institute and the pioneering work we’re doing together to fight the threat of viral disease. "We hope that our capabilities, paired with those at the Franklin, in time, will benefit patients around the world" Atul Saran, CEO, IntegerBio Wade Blair, CSO, Integer Bio #multiviraltherapeutics #integerbio #thefranklin Find out more here: https://zurl.co/f0z9
The Franklin is excited to share it's first licensing agreement with US-based biotech company IntegerBio. This partnership aims to progress the Franklin's nanobody discovery work into the next stages of drug development. This work has so far shown great promise in neutralising several coronavirus variants, and by working with IntegerBio, this technology can be used to develop new drugs for treatment in clinics. Find out more here: https://zurl.co/f0z9